Literature DB >> 325145

Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes.

B F Haynes, A S Fauci.   

Abstract

Con A-induced suppression of the direct PFC response to polyclonal stimulation in human B cells has been described. Two types of experiments are presented. First, Con A was added directly to PWM-stimulated PB or tonsil cells resulting in a dose-dependent suppression of the PFC response, with maximal suppression occurring at a Con A concentration of 10 mug/ml. This suppression is completely removed by the simultaneous addition of alphaMM to the cultures. Secondly, Con A stimulation of tonsil or PB lymphocytes generated a population of cells which when added to autologous lymphocyte cultures induced a marked and reproducible suppression of the PFC response. The generation of suppressor cells is dependent on cell division and is blocked by alpha MM. Once generated the process of suppression is indpendent of the presence of Con A itself and is mediated by an activated lymphocyte population. These studies demonstrate a simple and reproducible model for the generation of a population of suppressor cells capable of inhibiting the direct PFC response to PWM-induced polyclonal activation of normal human B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325145

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

2.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

3.  Suppression of B lymphocyte differentiation by newborn T lymphocytes with an Fc receptor for IgM.

Authors:  A R Hayward; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

4.  Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy.

Authors:  H Sakai; Y Nomoto; S Arimori
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

5.  Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

6.  Lymphocyte function in patients with chronic glomerulonephritis. Tests of suppressive activity generation by concanavalin A and antibody-dependent cellular cytotoxicity.

Authors:  Z Szewczyk; M Klinger; W Kopec; J Penar; E Kruźel
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

7.  B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  Cord blood B cell differentiation. Synergistic effect of pokeweed mitogen and Staphylococcus aureus on in vitro differentiation of B cells from human neonates.

Authors:  K M Miller; W B Pittard; R U Sorensen
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

10.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.